Articles

Kinome expression profiling to target new therapeutic avenues in multiple myeloma

IGH, CNRS, Université de Montpellier, Montpellier, France
IGH, CNRS, Université de Montpellier, Montpellier, France
IGH, CNRS, Université de Montpellier, Montpellier, France
Department of Hematology and Immunology, Myeloma Center Brussels, Vrije Universiteit Brussel, Brussels, Belgium
CHU Montpellier, Laboratory for Monitoring Innovative Therapies, Department of Biological Hematology, Montpellier, France
IGH, CNRS, Université de Montpellier, Montpellier, France
CHU Montpellier, Department of Clinical Hematology, Montpellier, France
Medizinische Klinik und Poliklinik V, Universitätsklinikum Heidelberg, Heidelberg, Germany;Nationales Centrum für Tumorerkrankungen, Heidelberg , Germany
CHU Montpellier, Department of Clinical Hematology, Montpellier, France;Université de Montpellier, UMR CNRS 5235, Montpellier, France;Université de Montpellier, UFR de Médecine, Montpellier, France
Medizinische Klinik und Poliklinik V, Universitätsklinikum Heidelberg, Heidelberg, Germany;Nationales Centrum für Tumorerkrankungen, Heidelberg , Germany
Department of Hematology and Immunology, Myeloma Center Brussels, Vrije Universiteit Brussel, Brussels, Belgium
IGH, CNRS, Université de Montpellier, Montpellier, France
IGH, CNRS, Université de Montpellier, Montpellier, France
IGH, CNRS, Université de Montpellier, Montpellier, France;CHU Montpellier, Laboratory for Monitoring Innovative Therapies, Department of Biological Hematology, Montpellier, France;Université de Montpellier, UFR de Médecine, Montpellier, France
Vol. 105 No. 3 (2020): March, 2020 https://doi.org/10.3324/haematol.2018.208306